Healthcare provider profile · identity verified

Nancy Ann Marshall, FNP

Nurse Practitioner · WOODLAWN, VA · NPI 1033461579

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	300	41
Furosemide	Furosemide	258	48
Potassium Chloride	Potassium Chloride	238	37
Atorvastatin Calcium	Atorvastatin Calcium	210	21
Gabapentin	Gabapentin	179	28
Pantoprazole Sodium	Pantoprazole Sodium	160	29
Lorazepam	Lorazepam	158	25
Trazodone Hcl	Trazodone Hcl	154	31
Rosuvastatin Calcium	Rosuvastatin Calcium	143	22
Omeprazole	Omeprazole	142	18
Quetiapine Fumarate	Quetiapine Fumarate	135	19
Metoprolol Tartrate	Metoprolol Tartrate	126	19
Escitalopram Oxalate	Escitalopram Oxalate	123	24
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	114	23
Amlodipine Besylate	Amlodipine Besylate	113	17
Sertraline Hcl	Sertraline Hcl	113	20
Eliquis	Apixaban	104	17
Lisinopril	Lisinopril	104	17
Tramadol Hcl	Tramadol Hcl	102	16
Aripiprazole	Aripiprazole	98	20
Mirtazapine	Mirtazapine	96	20
Buspirone Hcl	Buspirone Hcl	85	21
Donepezil Hcl	Donepezil Hcl	85	12
Losartan Potassium	Losartan Potassium	82	14
Divalproex Sodium	Divalproex Sodium	81	16
Ibuprofen	Ibuprofen	81	17
Famotidine	Famotidine	72	13
Ropinirole Hcl	Ropinirole Hcl	69	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	69	11
Ezetimibe	Ezetimibe	66	suppressed
Clonazepam	Clonazepam	65	12
Fluticasone Propionate	Fluticasone Propionate	65	11
Metformin Hcl	Metformin Hcl	64	suppressed
Memantine Hcl	Memantine Hcl	62	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	59	suppressed
Duloxetine Hcl	Duloxetine Hcl	57	suppressed
Montelukast Sodium	Montelukast Sodium	56	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	55	suppressed
Diclofenac Sodium	Diclofenac Sodium	51	suppressed
Jardiance	Empagliflozin	50	suppressed
Lactulose	Lactulose	50	13
Levetiracetam	Levetiracetam	48	suppressed
Carvedilol	Carvedilol	46	suppressed
Ondansetron Hcl	Ondansetron Hcl	46	14
Latanoprost	Latanoprost	45	suppressed
Trulicity	Dulaglutide	44	suppressed
Alprazolam	Alprazolam	41	suppressed
Metolazone	Metolazone	41	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	41	23
Clopidogrel	Clopidogrel Bisulfate	40	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	40	suppressed
Xarelto	Rivaroxaban	40	suppressed
Colestipol Hcl	Colestipol Hcl	39	suppressed
Meloxicam	Meloxicam	39	suppressed
Baclofen	Baclofen	38	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	38	suppressed
Olanzapine	Olanzapine	37	suppressed
Calcitriol	Calcitriol	36	suppressed
Benazepril Hcl	Benazepril Hcl	35	suppressed
Clonidine Hcl	Clonidine Hcl	32	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	31	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	31	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	31	suppressed
Sucralfate	Sucralfate	30	suppressed
Tizanidine Hcl	Tizanidine Hcl	30	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	29	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	28	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	27	15
Symbicort	Budesonide/Formoterol Fumarate	27	suppressed
Torsemide	Torsemide	27	suppressed
Carbamazepine	Carbamazepine	26	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	26	suppressed
Clozapine	Clozapine	26	suppressed
Fenofibrate	Fenofibrate	26	suppressed
Lamotrigine	Lamotrigine	26	suppressed
Cephalexin	Cephalexin	25	19
Finasteride	Finasteride	25	suppressed
Lidocaine	Lidocaine	25	suppressed
Nystatin	Nystatin	25	18
Azithromycin	Azithromycin	24	19
Hydralazine Hcl	Hydralazine Hcl	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	24	suppressed
Memantine Hcl Er	Memantine Hcl	24	suppressed
Benztropine Mesylate	Benztropine Mesylate	23	suppressed
Citalopram Hbr	Citalopram Hydrobromide	23	suppressed
Fluconazole	Fluconazole	23	18
Spironolactone	Spironolactone	23	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	22	suppressed
Atenolol	Atenolol	21	suppressed
Bumetanide	Bumetanide	21	suppressed
Levofloxacin	Levofloxacin	21	20
Alcohol Prep Pads	Alcohol Antiseptic Pads	20	suppressed
Glimepiride	Glimepiride	20	suppressed
Linzess	Linaclotide	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	19	suppressed
Diazepam	Diazepam	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Ketoconazole	Ketoconazole	19	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	19	suppressed
Digoxin	Digoxin	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Pravastatin Sodium	Pravastatin Sodium	18	suppressed
Risperidone	Risperidone	18	suppressed
Bupropion Xl	Bupropion Hcl	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Prazosin Hcl	Prazosin Hcl	17	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	16	suppressed
Loperamide	Loperamide Hcl	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	15	suppressed
Buprenorphine	Buprenorphine	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Methocarbamol	Methocarbamol	15	suppressed
Alendronate Sodium	Alendronate Sodium	14	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	14	suppressed
Metoprolol Succinate	Metoprolol Succinate	14	suppressed
Mometasone Furoate	Mometasone Furoate	14	suppressed
Quinine Sulfate	Quinine Sulfate	14	suppressed
Raloxifene Hcl	Raloxifene Hcl	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Chlorpromazine Hcl	Chlorpromazine Hcl	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Constulose	Lactulose	13	suppressed
Dalfampridine Er	Dalfampridine	13	suppressed
Glipizide	Glipizide	13	suppressed
Glycopyrrolate	Glycopyrrolate	13	suppressed
Imipramine Hcl	Imipramine Hcl	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Letrozole	Letrozole	13	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	13	suppressed
Modafinil	Modafinil	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Premarin	Estrogens, Conjugated	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	13
Valacyclovir	Valacyclovir Hcl	13	suppressed
Ceftriaxone	Ceftriaxone Sodium	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Lumigan	Bimatoprost	12	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	12	suppressed
Diltiazem Hcl	Diltiazem Hcl	11	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Humulin R	Insulin Regular, Human	11	suppressed
Invega Sustenna	Paliperidone Palmitate	11	suppressed
Lidocaine Hcl	Lidocaine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error